Public Company News

China Automotive Systems Announces Annual Meeting on September 24, 2024

CAAS announces the conference call and webcast information for the Annual Meeting of Stockholders to be held onTuesday, September 24, 2024 at 9:00 AM local time, or 9:00 PM EDT onMonday, September 23, 2024 WUHAN, China, Sept. 16, 2024 /PRNewswire/ -- China Automotive Systems, Inc. (Nasdaq: CAAS)...

2024-09-16 18:00 4404

Akeso's Ivonescimab plus Chemo in First-Line Triple-negative Breast Cancer Showed Promising Preliminary Efficacy and Good Safety at ESMO 2024

HONG KONG, Sept. 16, 2024 /PRNewswire/ -- At the 2024 European Society for Medical Oncology (ESMO) Conference, Akeso (9926.HK) published the phase 2 results from its ivonescimab in combination with chemotherapy as a first-line (1L) treatment for triple-negative breast cancer (TNBC). The prelimina...

2024-09-16 15:35 4463

Autoliv Appoints Adriana Karaboutis to its Board of Directors

STOCKHOLM, Sept. 16, 2024 /PRNewswire/ -- Autoliv, Inc. (NYSE: ALV) (SSE: ALIVsdb), the worldwide leader in automotive safety systems, announces that it has added a new independent member to its Board of Directors effective today. On September 13, 2024, the Autoliv Board of Directors appointed Ms...

2024-09-16 14:53 1487

Alphamab Oncology Presented the Latest Clinical Data from Two Studies on Anti-HER2 Bispecific ADC JSKN003 at the ESMO Congress 2024

SUZHOU, China, Sept. 16, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the latest clinical data from two studies on anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 were presented at the 2024 European Society for Medical Oncology Congress (ESMO Congress 202...

2024-09-16 13:03 1958

Risen Energy Champions Environmental Stewardship for a Greener Future

NINGBO, China, Sept. 15, 2024 /PRNewswire/ -- On September 20, World Cleanup Day 2024 kicks off during the Clean Up the World Weekend (CUW Weekend), themed "make room for life." Since joining the UN Global Compact (UNGC) in 2021, Risen Energy, a leader in global photovoltaic (PV) innovation, has ...

2024-09-16 10:00 1726

Temple Mall Presents "Blue-and-White Porcelain Impressions" Art Experience

Collaborating with Local Artist Angel Hui to Explore the Beauty of a Millennia-old Cultural Treasure * Temple Mall presents a themed event and exhibition celebrating blue-and-white porcelain, inviting the public to explore and appreciate the rich heritage of this millennia-old cultural treasur...

2024-09-16 09:00 2697

Akeso Published Ivonescimab plus Ligufalimab as First-Line Treatment for PD-L1-Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma at ESMO 2024

Head-to-Head Phase 3 Trial Compared to Pembrolizumab Initiated HONG KONG, Sept. 15, 2024 /PRNewswire/ -- At the 2024 European Society for Medical Oncology (ESMO) Conference, Akeso released the Phase 2 clinical results of its internally developed PD-1/VEGF bispecific antibody, ivonescimab, with or...

2024-09-15 15:10 2939

CNOOC Limited Successfully Withstands Super Typhoon "Yagi"

HONG KONG, Sept. 15, 2024 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883 (HKD Counter) and 80883 (RMB Counter), SSE: 600938) announces today that thanks to the Company's continuous focus on safety and environmental protection performance, as well as its mature typhoon response measures...

2024-09-15 10:41 6414

Breakthrough Therapy designation for Sanbexin sublingual tablets granted by the United States Food and Drug Administration

NANJING, China, Sept. 14, 2024 /PRNewswire/ -- On September 2, 2024, Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets), an innovative drug for stroke, has been granted the Breakthrough Therapy designation by the U...

2024-09-14 19:43 3493

Gan & Lee Pharmaceuticals Presented Two Positive Clinical Results of Once-weekly Insulin GZR4 at the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD 2024)

* In Phase Ia clinical study, GZR4 demonstrated favorable safety and tolerability profiles in healthy subjects, maintaining a stable glucose-lowering effect for up to one week with a single administration. * In Phase Ib clinical study, patients with Type 2 diabetes mellitus (T2DM) receiving s...

2024-09-14 19:00 4011

TIME, Statista Name Three SM companies Among World's Best Companies

PASAY CITY, Philippines, Sept. 14, 2024 /PRNewswire/ -- TIME Magazine and Statista have recognized SM Investments Corporation, SM Prime Holdings, and China Banking Corporation as among the World's Best Companies for 2024. This accolade underscores the group's focus and exceptional performance in ...

2024-09-14 17:04 3746

Harbour BioMed Announces the Latest Clinical Data on the First-in-Class Fully Human Anti-B7H7/HHLA2 Monoclonal Antibody HBM1020 at the ESMO Congress 2024

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Sept. 14, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immuno...

2024-09-14 16:06 3568

Sinopec Wins Best Environmental Protection Case at the First Sino-European Corporate ESG Best Practice Conference in Frankfurt

FRANKFURT, Germany, Sept. 14, 2024 /PRNewswire/ -- China Petroleum & Chemical Corporation (Sinopec, HKG: 0386) has been honored with the Best Environmental Protection Case award at the First Sino-European Corporate ESG Best Practice Conference inFrankfurt, Germ...

2024-09-14 12:23 4352

XCMG Unveils Major Lineup for MinExpo 2024, Showcasing Advanced Mining Solutions

LAS VEGAS, Sept. 13, 2024 /PRNewswire/ -- XCMG Machinery ("XCMG", SHE: 000425) is set to present its largest-ever collection of mining equipment at MinExpo 2024, taking place fromSeptember 24-26 in Las Vegas. Visitors can find XCMG at booth#329 in the North Hall, where the company will feature a ...

2024-09-14 11:19 2858

Live from ESMO 2024 | Ascentage Pharma Releases Latest Data Showing Sustained Clinical Efficacy of Olverembatinib in SDH-Deficient GIST during a Mini Oral Presentation

ROCKVILLE, Md. and SUZHOU, China, Sept. 14, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily for malignancies, today announced that it has released t...

2024-09-14 08:18 3745

Learning Tree International Celebrates 50 Years of Innovation, Impact, and Excellence

HERNDON, Va., Sept. 14, 2024 /PRNewswire/ -- Learning Tree International, a learning and development solutions company, proudly marks its 50th anniversary, celebrating half a century of transformative Innovation, profound Impact, and unwavering Excellence. This significant milestone underscores ...

2024-09-14 07:01 5176

Planet Image International Limited Reports the First Half of Fiscal Year 2024 Unaudited Financial Results

XINYU, China, Sept. 13, 2024 /PRNewswire/ -- Planet Image International Limited ("Planet Image," the "Company," "we," "our," or "us") (Nasdaq: YIBO), an export-oriented manufacturer and seller of compatible toner cartridges based in China, the U.S. and Europe, today announced its unaudited financi...

2024-09-14 04:45 6542

TOPBAND@2024 RE+, Exploring the Infinite Possibilities of Clean Energy

ANAHEIM, Calif., Sept. 13, 2024 /PRNewswire/ -- From September 10th to 12th, the RE+ exhibition, one of the most influential events in the energy sector, took place inAnaheim, USA. As an innovative leader in new energy, TOPBAND showcased itscutting-edge energy storage, charger, and integrated "P...

2024-09-13 21:00 1286

111 Inc. Announces Its Co-founders' Strategic Share Purchase and Highlights Continued Growth and Innovation

SHANGHAI, Sept. 13, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream inChina, today was informed by co-founders...

2024-09-13 19:30 5124

Cheetah Mobile Announces Second Quarter 2024 Unaudited Consolidated Financial Results

BEIJING, Sept. 13, 2024 /PRNewswire/ -- Cheetah Mobile Inc. (NYSE: CMCM) ("Cheetah Mobile" or the "Company"), a China-based IT company, today announced its unaudited consolidated financial results for the second quarter endedJune 30, 2024. Management Commentary Mr. Sheng Fu, Cheetah Mobile's Ch...

2024-09-13 17:00 5077
1 ... 61626364656667 ... 1605

Week's Top Stories